ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Jakjazz
|
221 |
46K |
19 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
221
|
46K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Jakjazz
|
221 |
46K |
9 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
221
|
46K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Jakjazz
|
221 |
46K |
12 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
221
|
46K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Jakjazz
|
221 |
46K |
11 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
221
|
46K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Jakjazz
|
221 |
46K |
2 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
221
|
46K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Jakjazz
|
221 |
46K |
8 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
221
|
46K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Jakjazz
|
221 |
46K |
5 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
221
|
46K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Jakjazz
|
221 |
46K |
2 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
221
|
46K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Jakjazz
|
221 |
46K |
8 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
221
|
46K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Jakjazz
|
221 |
46K |
6 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
221
|
46K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Jakjazz
|
1.1K |
295K |
52 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
52
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
Jakjazz
|
37 |
8.6K |
10 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
37
|
8.6K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
Jakjazz
|
37 |
8.6K |
5 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
37
|
8.6K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Jakjazz
|
311 |
77K |
11 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
311
|
77K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Jakjazz
|
1.1K |
295K |
13 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Jakjazz
|
1.1K |
295K |
11 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
Jakjazz
|
100 |
25K |
11 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
100
|
25K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Jakjazz
|
1.1K |
295K |
3 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Jakjazz
|
1.1K |
295K |
11 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Allan Border
|
|
Jakjazz
|
12 |
2.6K |
5 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
12
|
2.6K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Jakjazz
|
77 |
18K |
18 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
18K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Jakjazz
|
77 |
18K |
7 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
18K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Jakjazz
|
77 |
18K |
13 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
18K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Jakjazz
|
77 |
18K |
14 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
18K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Jakjazz
|
1.1K |
295K |
10 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
10
|
|
ASX - By Stock
|
PTX |
Re:
Live Investor Briefing - today
|
|
Jakjazz
|
27 |
10K |
0 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
27
|
10K
|
0
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Jakjazz
|
1.1K |
295K |
36 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
36
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Jakjazz
|
1.1K |
295K |
6 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Jakjazz
|
1.1K |
295K |
9 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
Jakjazz
|
66 |
17K |
26 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
66
|
17K
|
26
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Jakjazz
|
1.1K |
295K |
13 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Jakjazz
|
1.1K |
295K |
7 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Media clarification
|
|
Jakjazz
|
62 |
16K |
23 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
62
|
16K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
Jakjazz
|
55 |
14K |
3 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
55
|
14K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Media clarification
|
|
Jakjazz
|
62 |
16K |
5 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
62
|
16K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
Jakjazz
|
55 |
14K |
12 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
55
|
14K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Media clarification
|
|
Jakjazz
|
62 |
16K |
18 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
62
|
16K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Jakjazz
|
58 |
16K |
7 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
58
|
16K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Jakjazz
|
58 |
16K |
11 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
58
|
16K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Jakjazz
|
196 |
36K |
11 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
196
|
36K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Jakjazz
|
196 |
36K |
16 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
196
|
36K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Jakjazz
|
196 |
36K |
4 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
196
|
36K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Jakjazz
|
196 |
36K |
8 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
196
|
36K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Jakjazz
|
126 |
31K |
11 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
126
|
31K
|
11
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Exceptional High-Grade Zn, Pb and Ag Mineralisation at Ajana
|
|
Jakjazz
|
41 |
13K |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
41
|
13K
|
1
|
|
ASX - By Stock
|
NC6 |
Re:
Ann: NC6 Selected for Fashion For Goods 2024 Innovation Programme
|
|
Jakjazz
|
5 |
2.1K |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
5
|
2.1K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Jakjazz
|
1.1K |
295K |
14 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
1.1K
|
295K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Jakjazz
|
1.1K |
295K |
16 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
1.1K
|
295K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Jakjazz
|
311 |
77K |
19 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
311
|
77K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
what odds of house deposit
|
|
Jakjazz
|
14 |
3.5K |
6 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
14
|
3.5K
|
6
|
|